文献速递肾移植

非HLA抗体加重肾移植抗体介导排斥的组织学表型与预后

Non-HLA antibodies worsen the histological phenotype and prognosis of antibody mediated rejection in kidney allografts.
PubMed 文献 · Kidney Int · 2026-07-25

该研究分析326例AMRh患者和164例稳定对照的571份血清,发现非HLA抗体在AMRh患者中升高并与微血管炎症严重度相关。双阳性患者移植肾存活最差,非HLA抗体独立预测移植物丢失(HR 2.25,95%CI 1.03-4.92),外部验证重现该关联。

要点

  • 非HLA抗体与AMRh患者微血管炎症严重度相关,独立于HLA-DSA状态
  • HLA-DSA与非HLA抗体双阳性患者移植物存活最差
  • 非HLA抗体独立预测移植物丢失(HR 2.25,95%CI 1.03-4.92)

核心结论

  • 移植后检测非HLA抗体可识别组织学更严重且预后更差的AMR亚群,尤其当与HLA-DSA共存时。
  • 将非HLA抗体检测整合入现有诊断框架可能优化AMR分类和风险分层。

研究设计与样本

  • 研究纳入326例具有AMR组织学特征(AMRh)的患者和164例稳定对照,分析571份移植后血清样本。
  • 非HLA抗体用NHADIA检测,活检按Banff 2022标准评分,患者按HLA-DSA和NHADIA状态分层。
  • 外部验证在独立肾移植队列中进行,包括189例患者的211份活检。

主要发现

  • AMRh患者的NHADIA值显著高于对照,无论HLA-DSA状态如何。
  • NHADIA值与肾小球炎、管周毛细血管炎和整体微血管炎症评分严重度相关。
  • 在AMRh且HLA-DSA阳性患者中,非HLA抗体仍独立与微血管炎症严重度相关。
  • 随访活检显示HLA-DSA和非HLA抗体双阳性患者AMR病变持续。
  • 双阳性患者移植物存活最低,NHADIA阳性独立且显著预测移植物丢失(HR 2.25,95%CI 1.03-4.92)。

关键数值与推荐

  • 非HLA抗体与Banff病变严重度和死亡删失移植物存活的关联在外部验证队列中重现。

临床怎么用

  • 对AMRh患者可考虑检测非HLA抗体以细化风险分层,尤其HLA-DSA阳性者。
  • 双阳性患者可能需更密切监测和个体化管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Antibody-mediated rejection (AMR) remains a leading cause of kidney allograft failure, with both HLA and non-HLA antibodies implicated in its pathogenesis. The contribution of non-HLA antibodies (non-HLA Abs) to microvascular inflammation (MVI) and graft outcome, particularly in cases lacking donor-specific anti-HLA antibodies (HLA-DSAs), remains incompletely understood. METHODS: We analyzed 571 post-transplant serum samples from 326 patients with histological features of AMR (AMRh) and 164 stable control individuals. Non-HLA Abs were detected using the previously developed Non-HLA Antibody Detection Immunoassay (NHADIA), and associations were examined with histological lesions, AMRh persistence, and graft outcomes. Biopsies were scored according to Banff 2022 criteria, and patients were stratified by HLA-DSA and NHADIA status. External validation was also performed in an independent kidney transplant cohort that included 211 biopsies from 189 patients. RESULTS: NHADIA values were significantly higher in patients with AMRh compared to controls, regardless of HLA-DSA status. NHADIA values correlated with the severity of glomerulitis, peritubular capillaritis and global MVI scores. In patients with AMRh and HLA-DSAs, non-HLA Abs remained independently associated with MVI severity. Follow-up biopsies revealed persistent AMR lesions in patients with both HLA-DSAs and non-HLA Abs. Allograft survival was lowest in double-positive patients, and NHADIA positivity independently and significantly predicted graft loss (hazard ratio 2.25, 95% confidence interval 1.03-4.92). Association of non-HLA Abs with Banff lesions severity and death-censored graft survival was replicated in the external validation cohort. CONCLUSIONS: Post-transplant detection of non-HLA antibodies identifies a distinct subset of AMR with more severe histology and worse graft prognosis, particularly when coexisting with HLA-DSAs. Integrating non-HLA Ab testing into current diagnostic frameworks may refine AMR classification and improve risk stratification.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Lebraud E, Aubert O, Aouni L, et al. Non-HLA antibodies worsen the histological phenotype and prognosis of antibody mediated rejection in kidney allografts. Kidney Int. 2026. PMID: 42498055. doi:10.1016/j.kint.2026.06.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。